You are here:Home-Chemical Inhibitors & Agonists-JAK/STAT Signaling-JAK-GDC-046
GDC-046

Chemical Structure : GDC-046

CAS No.: 1258292-64-6

GDC-046 (GDC046)

Catalog No.: PC-38049Not For Human Use, Lab Use Only.

GDC-046 is a potent, selective, and orally bioavailable inhibitor of TYK2 with  with Kis of 4.8, 0.7, 0.7, and 0.4 nM for TYK2, JAK1, JAK2, and JAK3, respectively.

Packing Price Stock Quantity
5 mg $198 In stock
10 mg $328 In stock
50 mg $798 In stock
100 mg $1280 In stock

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

GDC-046 is a potent, selective, and orally bioavailable inhibitor of TYK2 with  with Kis of 4.8, 0.7, 0.7, and 0.4 nM for TYK2, JAK1, JAK2, and JAK3, respectively.
GDC-046 demonstrates reasonable potency in blocking the IL-12 pathway (IL-12 pSTAT4 EC50=380 nM) in cell based assays.
GDC-046 also displays less activity in the EPO (JAK2) pathway (EPO pSTAT5 EC50=1700 nM), and IL-6 (JAK1) pathway (IL-6 pSTAT3 EC50=2000 nM).
GDC-046 shows statistically significant knockdown of cytokine interferon-γ (IFNγ), in a mouse IL-12 PK/PD model.

Physicochemical Properties

M.Wt 350.199
Formula C16H13Cl2N3O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

2,6-dichloro-N-(2-(cyclopropanecarboxamido)pyridin-4-yl)benzamide

References

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: